Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 11230374)

Published in Hypertension on February 01, 2001

Authors

A Fiebeler1, F Schmidt, D N Müller, J K Park, R Dechend, M Bieringer, E Shagdarsuren, V Breu, H Haller, F C Luft

Author Affiliations

1: Franz Volhard Clinic and Max Delbrück Center, Medical Faculty of the Charité, Humboldt University of Berlin, Germany.

Articles citing this

ECM remodeling in hypertensive heart disease. J Clin Invest (2007) 4.03

Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res (2008) 1.76

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation (2004) 1.72

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int (2012) 1.60

Aldosterone stimulates surface expression of NHE3 in renal proximal brush borders. Pflugers Arch (2003) 1.47

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A (2009) 1.40

Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol (2013) 1.22

Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol (2010) 1.21

Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int (2009) 1.17

Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension (2010) 1.10

Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev (2005) 1.05

Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens (2011) 1.03

Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression. Am J Physiol Heart Circ Physiol (2011) 1.02

Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease. Nat Rev Nephrol (2013) 1.01

The mineralocorticoid receptor and oxidative stress. Heart Fail Rev (2005) 0.98

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus. Mol Ther (2011) 0.98

Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities. Int J Hypertens (2012) 0.97

Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol (2013) 0.93

Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta. Endocrinology (2008) 0.90

Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction. Int J Inflam (2012) 0.89

The multifaceted mineralocorticoid receptor. Compr Physiol (2014) 0.85

Effect of spironolactone on cardiac remodeling after acute myocardial infarction. World J Emerg Med (2013) 0.83

Aldosterone-induced kidney injury is mediated by NFκB activation. Clin Exp Nephrol (2010) 0.83

Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism. Am J Physiol Heart Circ Physiol (2009) 0.79

Relaxin does not improve Angiotensin II-induced target-organ damage. PLoS One (2014) 0.77

Understanding and treating hypertension in diabetic populations. Cardiovasc Diagn Ther (2015) 0.76

Cardiac actions of fibroblast growth factor 23. Bone (2016) 0.75

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature. J Endocrinol (2017) 0.75

Articles by these authors

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79

Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet (2000) 4.12

Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99

Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28

Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother (1976) 2.98

Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis (1974) 2.93

The prevalence of premature ejaculation and its clinical characteristics in Korean men according to different definitions. Int J Impot Res (2012) 2.88

Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res (2000) 2.76

AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension (1986) 2.51

Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol Cell Biol (1999) 2.27

Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26

Infiltrates in protocol biopsies from renal allografts. Am J Transplant (2007) 2.24

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22

ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology. J Am Coll Cardiol (1998) 2.22

Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22

Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19

Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther (1994) 2.14

The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil (2005) 2.11

Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) (2008) 2.11

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (2000) 2.06

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension (2001) 2.04

Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett (1997) 2.03

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant (1996) 2.01

Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med (2001) 2.00

The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun (1992) 1.91

Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res (2001) 1.88

Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med (1998) 1.86

An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis (2001) 1.86

Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis (1995) 1.85

Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83

Critical thinking in graduate medical education: A role for concept mapping assessment? JAMA (2000) 1.74

Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region. J Sex Med (2011) 1.73

Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72

Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res (2000) 1.71

Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab (1998) 1.70

Bone-muscle strength indices for the human lower leg. Bone (2000) 1.65

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature (1993) 1.62

CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature (1991) 1.60

Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother (1981) 1.58

Overnight urine collections to estimate sodium intake. Hypertension (1983) 1.58

The pathology of so-called Mediterranean abdominal lymphoma with malabsorption. Cancer (1972) 1.57

Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57

Site of action of a ribosomal RNA methylase conferring resistance to thiostrepton. J Biol Chem (1982) 1.56

Evolutionary relationship between Tn21-like elements and pBP201, a plasmid from Klebsiella pneumoniae mediating resistance to gentamicin and eight other drugs. Mol Gen Genet (1984) 1.54

Twin zygosity. Automated determination with microsatellites. J Reprod Med (1997) 1.53

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51

Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn (1998) 1.50

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest (2003) 1.49

Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49

The role of insertions, deletions, and substitutions in the evolution of R6 related plasmids encoding aminoglycoside transferase ANT-(2"). Mol Gen Genet (1984) 1.49

Time for action. Arch Intern Med (1991) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J (1998) 1.48

Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother (1976) 1.45

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology (2001) 1.45

Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45

A region on chromosome 3 is linked to dizygotic twinning. Nat Genet (2000) 1.44

Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices. AJNR Am J Neuroradiol (2007) 1.44

Right-sided chest pain at the onset of haemodialysis. Nephrol Dial Transplant (2001) 1.44

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43

Contrast-enhanced spiral CT of the head and neck: comparison of contrast material injection rates. AJNR Am J Neuroradiol (1999) 1.43

The tell-tale urinary chloride. Nephrol Dial Transplant (2001) 1.39

Kidneys from pediatric donors: risk versus benefit. Clin Nephrol (1994) 1.39

Design and clinical application of a low-pass input filter for the evaluation of intracardiac electrograms during radiofrequency catheter ablation. Am J Cardiol (1993) 1.38

STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant (2000) 1.38

Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38

A left-to-left shunt. Am J Med (1999) 1.38

Observation of cells resembling Sternberg-Reed cells in conditions other than Hodgkin's disease. Cancer (1970) 1.37

Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant (2013) 1.36

Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36

Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant (2011) 1.36

Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35

A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35

Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res (1996) 1.34

Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34

Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32